{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:18:24Z","timestamp":1787728704106,"version":"build-2784847793"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001222"],"award-info":[{"award-number":["82001222"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013318","name":"Shanxi Science and Technology Department","doi-asserted-by":"crossref","award":["202203021212037"],"award-info":[{"award-number":["202203021212037"]}],"id":[{"id":"10.13039\/501100013318","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>GNE myopathy is a rare autosomal recessive distal myopathy caused by mutations in UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase (GNE), a bifunctional enzyme critical for sialic acid biosynthesis. This study aimed to describe a novel autosomal recessive <jats:italic>GNE<\/jats:italic> pedigree in a Chinese family and explore the possible mechanism of <jats:italic>GNE<\/jats:italic> variants in GNE myopathy, the most common distal myopathy in China. The clinical, genetic, and pathological characteristics of 216 Chinese patients with GNE myopathy were also summarized.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The proband and her family underwent a comprehensive medical history assessment and neurological examinations. Whole-exome sequencing was performed on the proband, and Sanger sequencing was performed on family members. 293T cell lines were used for immunofluorescence (IF), Western blot, and dual-luciferase reporter assays. We collected the clinical data of 216 GNE myopathy patients from previous reports up until August 1, 2024. Patients were classified into distinct groups according to mutation location to analyze genotype-phenotype correlation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Whole-exome sequencing of the proband and Sanger sequencing of all available family members identified a compound heterozygous mutation involving a novel promoter region mutation, c.-259T\u2009&gt;\u2009C, and a reported mutation, c.88\u00a0C\u2009&gt;\u2009T (p.Q30*). The <jats:italic>GNE<\/jats:italic> promoter fragment (-500 to -1; c.-259T\u2009&gt;\u2009C) was cloned to construct the firefly luciferase reporter vector. The dual-luciferase reporter assay showed that the mutated promoter exhibited reduced transcriptional activity, resulting in decreased GNE expression. Western blot and IF analysis of overexpressing Q30* revealed that it reduced GNE expression without altering cellular localization and increased the ectopic cytoplasmic expression of TDP-43. The p.D207V mutation was the most common variant in China. Patients carrying p.D207V tended to experience later disease onset. In the epimerase\/epimerase group, men experienced earlier disease onset than women (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). In other groups, age at disease onset in females was earlier than that in males.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The c.-259T\u2009&gt;\u2009C mutation decreases promoter activity, while the c.88\u00a0C\u2009&gt;\u2009T (p.Q30*) mutation reduces GNE expression and affects TDP-43 distribution, thus affecting normal cellular function. The p.D207V mutation is the most common <jats:italic>GNE<\/jats:italic> variant in China and is associated with milder disease progression.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03696-2","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T12:54:39Z","timestamp":1743857679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Analysis of the pathogenicity of novel GNE mutations and clinical, pathological, and genetic characteristics of GNE myopathy in Chinese population"],"prefix":"10.1186","volume":"20","author":[{"given":"Yingming","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renlong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2599-1034","authenticated-orcid":false,"given":"Xueli","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"issue":"4","key":"3696_CR1","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/jnnp-2013-307051","volume":"86","author":"I Nishino","year":"2015","unstructured":"Nishino I, Carrillo-Carrasco N, Argov Z. GNE myopathy: current update and future therapy. J Neurol Neurosurg Psychiatry. 2015;86(4):385\u201392. https:\/\/doi.org\/10.1136\/jnnp-2013-307051","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"3696_CR2","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/humu.22583","volume":"35","author":"FV Celeste","year":"2014","unstructured":"Celeste FV, Vilboux T, Ciccone C, de Dios JK, Malicdan MC, Leoyklang P, et al. Mutation update for GNE gene variants associated with GNE myopathy. Hum Mutat. 2014;35(8):915\u201326. https:\/\/doi.org\/10.1002\/humu.22583","journal-title":"Hum Mutat"},{"issue":"3","key":"3696_CR3","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000061520.63546.8f","volume":"61","author":"I Yabe","year":"2003","unstructured":"Yabe I, Higashi T, Kikuchi S, Sasaki H, Fukazawa T, Yoshida K, et al. GNE mutations causing distal myopathy with rimmed vacuoles with inflammation. Neurology. 2003;61(3):384\u20136. https:\/\/doi.org\/10.1212\/01.wnl.0000061520.63546.8f","journal-title":"Neurology"},{"issue":"1","key":"3696_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1212\/wnl.61.1.145","volume":"61","author":"S Hinderlich","year":"2003","unstructured":"Hinderlich S, Salama I, Eisenberg I, Mitrani-Rosenbaum S. Distal myopathy with rimmed vacuoles is allelic to hereditary inclusion body myopathy. Neurology. 2003;61(1):145. https:\/\/doi.org\/10.1212\/wnl.61.1.145.; author reply.","journal-title":"Neurology"},{"key":"3696_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1471-2350-12-87","volume":"12","author":"SE Boyden","year":"2011","unstructured":"Boyden SE, Duncan AR, Estrella EA, Lidov HG, Mahoney LJ, Katz JS, et al. Molecular diagnosis of hereditary inclusion body myopathy by linkage analysis and identification of a novel splice site mutation in GNE. BMC Med Genet. 2011;12:87. https:\/\/doi.org\/10.1186\/1471-2350-12-87","journal-title":"BMC Med Genet"},{"issue":"2","key":"3696_CR6","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000341561","volume":"4","author":"Y Ikeda-Sakai","year":"2012","unstructured":"Ikeda-Sakai Y, Manabe Y, Fujii D, Kono S, Narai H, Omori N, et al. Novel mutations of the GNE gene in distal myopathy with rimmed vacuoles presenting with very slow progression. Case Rep Neurol. 2012;4(2):120\u20135. https:\/\/doi.org\/10.1159\/000341561","journal-title":"Case Rep Neurol"},{"issue":"10","key":"3696_CR7","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41580-018-0028-8","volume":"19","author":"V Haberle","year":"2018","unstructured":"Haberle V, Stark A. Eukaryotic core promoters and the functional basis of transcription initiation. Nat Rev Mol Cell Biol. 2018;19(10):621\u201337. https:\/\/doi.org\/10.1038\/s41580-018-0028-8","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"3696_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3109\/07853899209166991","volume":"24","author":"DN Cooper","year":"1992","unstructured":"Cooper DN. Regulatory mutations and human genetic disease. Ann Med. 1992;24(6):427\u201337. https:\/\/doi.org\/10.3109\/07853899209166991","journal-title":"Ann Med"},{"issue":"1","key":"3696_CR9","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0022-510x(81)90067-8","volume":"51","author":"I Nonaka","year":"1981","unstructured":"Nonaka I, Sunohara N, Ishiura S, Satoyoshi E. Familial distal myopathy with rimmed vacuole and lamellar (myeloid) body formation. J Neurol Sci. 1981;51(1):141\u201355. https:\/\/doi.org\/10.1016\/0022-510x(81)90067-8","journal-title":"J Neurol Sci"},{"issue":"1","key":"3696_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0022-510x(84)90053-4","volume":"64","author":"Z Argov","year":"1984","unstructured":"Argov Z, Yarom R. Rimmed vacuole myopathy sparing the quadriceps. A unique disorder in Iranian Jews. J Neurol Sci. 1984;64(1):33\u201343. https:\/\/doi.org\/10.1016\/0022-510x(84)90053-4","journal-title":"J Neurol Sci"},{"issue":"4","key":"3696_CR11","doi-asserted-by":"publisher","first-page":"W284","DOI":"10.2214\/ajr.10.4247","volume":"194","author":"CJ McMahon","year":"2010","unstructured":"McMahon CJ, Wu JS, Eisenberg RL. Muscle edema. AJR Am J Roentgenol. 2010;194(4):W284\u201392. https:\/\/doi.org\/10.2214\/ajr.10.4247","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"3696_CR12","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/mgg3.300","volume":"5","author":"J Garland","year":"2017","unstructured":"Garland J, Stephen J, Class B, Gruber A, Ciccone C, Poliak A, et al. Identification of an Alu element-mediated deletion in the promoter region of GNE in siblings with GNE myopathy. Mol Genet Genom Med. 2017;5(4):410\u20137. https:\/\/doi.org\/10.1002\/mgg3.300","journal-title":"Mol Genet Genom Med"},{"issue":"1","key":"3696_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/mus.26486","volume":"60","author":"S Chakravorty","year":"2019","unstructured":"Chakravorty S, Berger K, Arafat D, Nallamilli BRR, Subramanian HP, Joseph S, et al. Clinical utility of RNA sequencing to resolve unusual GNE myopathy with a novel promoter deletion. Muscle Nerve. 2019;60(1):98\u2013103. https:\/\/doi.org\/10.1002\/mus.26486","journal-title":"Muscle Nerve"},{"issue":"8","key":"3696_CR14","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00246-012-0346-0","volume":"33","author":"S Pang","year":"2012","unstructured":"Pang S, Shan J, Qiao Y, Ma L, Qin X, Wanyan H, et al. Genetic and functional analysis of the NKX2-5 gene promoter in patients with ventricular septal defects. Pediatr Cardiol. 2012;33(8):1355\u201361. https:\/\/doi.org\/10.1007\/s00246-012-0346-0","journal-title":"Pediatr Cardiol"},{"issue":"10","key":"3696_CR15","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1136\/jclinpath-2017-204378","volume":"70","author":"P Ropero","year":"2017","unstructured":"Ropero P, Erquiaga S, Arrizabalaga B, P\u00e9rez G, de la Iglesia S, Torrej\u00f3n MJ, et al. Phenotype of mutations in the promoter region of the \u03b2-globin gene. J Clin Pathol. 2017;70(10):874\u20138. https:\/\/doi.org\/10.1136\/jclinpath-2017-204378","journal-title":"J Clin Pathol"},{"key":"3696_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/128_2013_464","volume":"366","author":"S Hinderlich","year":"2015","unstructured":"Hinderlich S, Weidemann W, Yardeni T, Horstkorte R, Huizing M. UDP-GlcNAc 2-Epimerase\/ManNAc kinase (GNE): A master regulator of Sialic acid synthesis. Top Curr Chem. 2015;366:97\u2013137. https:\/\/doi.org\/10.1007\/128_2013_464","journal-title":"Top Curr Chem"},{"key":"3696_CR17","doi-asserted-by":"publisher","first-page":"103396","DOI":"10.1016\/j.mcn.2019.103396","volume":"100","author":"J Gao","year":"2019","unstructured":"Gao J, Wang L, Yan T, Perry G, Wang X. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration. Mol Cell Neurosci. 2019;100:103396. https:\/\/doi.org\/10.1016\/j.mcn.2019.103396","journal-title":"Mol Cell Neurosci"},{"issue":"5796","key":"3696_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal Lobar degeneration and amyotrophic lateral sclerosis. Sci (New York NY). 2006;314(5796):130\u20133. https:\/\/doi.org\/10.1126\/science.1134108","journal-title":"Sci (New York NY)"},{"issue":"2","key":"3696_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s00401-008-0471-2","volume":"117","author":"B K\u00fcsters","year":"2009","unstructured":"K\u00fcsters B, van Hoeve BJ, Schelhaas HJ, Ter Laak H, van Engelen BG, Lammens M. TDP-43 accumulation is common in myopathies with rimmed vacuoles. Acta Neuropathol. 2009;117(2):209\u201311. https:\/\/doi.org\/10.1007\/s00401-008-0471-2","journal-title":"Acta Neuropathol"},{"issue":"1","key":"3696_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41536-022-00238-3","volume":"7","author":"RE Schmitt","year":"2022","unstructured":"Schmitt RE, Smith DYt, Cho DS, Kirkeby LA, Resch ZT, Liewluck T, et al. Myogenesis defects in a patient-derived iPSC model of hereditary GNE myopathy. NPJ Regenerative Med. 2022;7(1):48. https:\/\/doi.org\/10.1038\/s41536-022-00238-3","journal-title":"NPJ Regenerative Med"},{"issue":"3","key":"3696_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.molcel.2020.06.019","volume":"79","author":"C Wang","year":"2020","unstructured":"Wang C, Duan Y, Duan G, Wang Q, Zhang K, Deng X, et al. Stress induces dynamic, Cytotoxicity-Antagonizing TDP-43 nuclear bodies via paraspeckle LncRNA NEAT1-Mediated Liquid-Liquid phase separation. Mol Cell. 2020;79(3):443\u2013e587. https:\/\/doi.org\/10.1016\/j.molcel.2020.06.019","journal-title":"Mol Cell"},{"key":"3696_CR22","doi-asserted-by":"publisher","unstructured":"Mashangva F, Singh S, Oswalia J, Arya R. Understanding pathophysiology of GNE myopathy and current progress towards drug development. J Biosci. 2024;49:29. https:\/\/doi.org\/10.1007\/s12038-023-00414-7","DOI":"10.1007\/s12038-023-00414-7"},{"issue":"1","key":"3696_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s10038-018-0525-9","volume":"64","author":"Y Chen","year":"2019","unstructured":"Chen Y, Xi J, Zhu W, Lin J, Luo S, Yue D, et al. GNE myopathy in Chinese population: hotspot and novel mutations. J Hum Genet. 2019;64(1):11\u20136. https:\/\/doi.org\/10.1038\/s10038-018-0525-9","journal-title":"J Hum Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03696-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03696-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03696-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T12:54:40Z","timestamp":1743857680000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03696-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3696"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03696-2","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics System Committee of the First Hospital of Shanxi Medical University (KYLL-2024-220).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree with the content of the manuscript, and all patients or legal guardians consented to the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors state that there is no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}